During the past decade, Landeskrankenhaus Hall Gedächtnisambulanz conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Landeskrankenhaus Hall Gedächtnisambulanz" are "Alzheimer's Disease" (1 trials) and "Alzheimer´s Disease" (1 trials). Many other conditions were trialed in "Landeskrankenhaus Hall Gedächtnisambulanz" in a lesser frequency.

Most popular intervention types in "Landeskrankenhaus Hall Gedächtnisambulanz" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "AFFITOPE® AD02" (1 trials), "Placebo" (1 trials), "active: AFFITOPE AD02" (1 trials) and "control: Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Landeskrankenhaus Hall Gedächtnisambulanz" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Landeskrankenhaus Hall Gedächtnisambulanz". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Landeskrankenhaus Hall Gedächtnisambulanz, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Landeskrankenhaus Hall Gedächtnisambulanz, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".